| (S)-nicotine | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of Nicotine | CTD | PMID:12504349 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:734270 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO3 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO3 mRNA | CTD | PMID:21215274 PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO3 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FMO3 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:16214954 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FMO3 promoter] | CTD | PMID:21889950 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:20036217 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:20036217 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:20036217 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA | CTD | PMID:16214954 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FMO3 enhancer]; more ... | CTD | PMID:18765683 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO3 mRNA] | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734271 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of FMO3 mRNA | CTD | PMID:16214954 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:734271 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO3 mRNA] | CTD | PMID:16054899 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:734271 | 6480464 | AHR protein affects the reaction [Methylcholanthrene results in increased expression of FMO3 mRNA]; more ... | CTD | PMID:20570689 |
| 3-methylcholanthrene | increases expression | ISO | RGD:734271 | 6480464 | Methylcholanthrene results in increased expression of FMO3 mRNA | CTD | PMID:20570689 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:734271 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of FMO3 mRNA | CTD | PMID:18648102 |
| aflatoxin B1 | decreases expression | ISO | RGD:734270 | 6480464 | Aflatoxin B1 results in decreased expression of FMO3 mRNA | CTD | PMID:22100608 |
| almotriptan | increases oxidation | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased oxidation of almotriptan | CTD | PMID:12642466 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FMO3 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:734271 | 6480464 | Benzo(a)pyrene results in increased expression of FMO3 mRNA | CTD | PMID:20570689 PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:734271 | 6480464 | Benzo(a)pyrene results in increased expression of FMO3 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:734271 | 6480464 | Benzo(a)pyrene results in increased expression of FMO3 mRNA | CTD | PMID:21569818 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of FMO3 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | increases expression | ISO | RGD:734271 | 6480464 | Benzo(a)pyrene results in increased expression of FMO3 mRNA | CTD | PMID:20570689 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:734271 | 6480464 | Benzo(a)pyrene results in increased expression of FMO3 mRNA | CTD | PMID:19770486 PMID:20570689 |
| benzo[a]pyrene | increases expression | ISO | RGD:734271 | 6480464 | Benzo(a)pyrene results in increased expression of FMO3 mRNA | CTD | PMID:20570689 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:734271 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of FMO3 mRNA]; more ... | CTD | PMID:20570689 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of FMO3 mRNA | CTD | PMID:19167457 |
| cholic acid | increases expression | ISO | RGD:734271 | 6480464 | Cholic Acid results in increased expression of FMO3 mRNA | CTD | PMID:17521389 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of FMO3 mRNA | CTD | PMID:17602206 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FMO3 mRNA | CTD | PMID:17602206 |
| cycloheximide | increases expression | ISO | RGD:734271 | 6480464 | Cycloheximide results in increased expression of FMO3 mRNA | CTD | PMID:20570689 |
| cyclosporin A | decreases expression | ISO | RGD:734270 | 6480464 | Cyclosporine results in decreased expression of FMO3 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FMO3 mRNA | CTD | PMID:21865292 |
| dexamethasone | multiple interactions | ISO | RGD:734271 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO3 mRNA; more ... | CTD | PMID:16054899 |
| ethanol | increases expression | ISO | RGD:734271 | 6480464 | Ethanol results in increased expression of FMO3 mRNA | CTD | PMID:19167417 |
| fumonisin B1 | decreases expression | ISO | RGD:734271 | 6480464 | fumonisin B1 results in decreased expression of FMO3 mRNA | CTD | PMID:16221962 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of FMO3 gene | CTD | PMID:22079235 |
| methimazole | affects metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 gene polymorphism affects the metabolism of Methimazole | CTD | PMID:17050781 |
| methimazole | multiple interactions | EXP | | 6480464 | Thioacetamide inhibits the reaction [FMO3 protein results in increased oxidation of Methimazole]; more ... | CTD | PMID:11414682 |
| methimazole | increases oxidation | EXP | | 6480464 | FMO3 protein results in increased oxidation of Methimazole | CTD | PMID:11414682 |
| methimazole | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of Methimazole | CTD | PMID:17050781 |
| methotrexate | affects expression | ISO | RGD:734271 | 6480464 | Methotrexate affects the expression of FMO3 mRNA | CTD | PMID:18502557 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of FMO3 mRNA | CTD | PMID:16809437 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:734271 | 6480464 | Diethylnitrosamine results in increased expression of FMO3 mRNA | CTD | PMID:18691550 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FMO3 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:734271 | 6480464 | IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of FMO3 mRNA]; more ... | CTD | PMID:18691550 |
| naphthalene | decreases expression | ISO | RGD:734271 | 6480464 | naphthalene results in decreased expression of FMO3 mRNA | CTD | PMID:18757308 |
| paracetamol | decreases expression | ISO | RGD:734271 | 6480464 | Acetaminophen results in decreased expression of FMO3 mRNA | CTD | PMID:18544908 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of FMO3 mRNA | CTD | PMID:17366322 |
| perazine | increases oxidation | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased oxidation of Perazine | CTD | PMID:11026737 |
| pirinixic acid | multiple interactions | ISO | RGD:734271 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of FMO3 mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:734271 | 6480464 | pirinixic acid results in decreased expression of FMO3 mRNA | CTD | PMID:16221962 PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:734271 | 6480464 | pirinixic acid results in decreased expression of FMO3 mRNA | CTD | PMID:20813756 PMID:16221962 |
| ranitidine | affects metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein affects the metabolism of Ranitidine | CTD | PMID:15286053 |
| rosiglitazone | multiple interactions | ISO | RGD:734271 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO3 mRNA; more ... | CTD | PMID:16054899 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:734270 | 6480464 | Buthionine Sulfoximine inhibits the reaction [FMO3 protein results in increased susceptibility to Thiourea] | CTD | PMID:12093470 |
| sulindac | affects metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 gene polymorphism affects the metabolism of Sulindac | CTD | PMID:17050781 |
| sulindac | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of Sulindac | CTD | PMID:15623613 PMID:17050781 |
| sulindac | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of Sulindac | CTD | PMID:17050781 PMID:15623613 |
| sulindac | multiple interactions | ISO | RGD:734270 | 6480464 | FMO3 gene polymorphism results in decreased metabolism of and results in increased susceptibility to Sulindac | CTD | PMID:15623613 |
| testosterone | decreases expression | ISO | RGD:734271 | 6480464 | Testosterone results in decreased expression of FMO3 mRNA | CTD | PMID:21669218 PMID:20844152 |
| testosterone | decreases expression | ISO | RGD:734271 | 6480464 | Testosterone results in decreased expression of FMO3 mRNA | CTD | PMID:20844152 PMID:21669218 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of FMO3 mRNA | CTD | PMID:16239168 |
| thioacetamide | multiple interactions | EXP | | 6480464 | Thioacetamide inhibits the reaction [FMO3 protein results in increased oxidation of Methimazole] | CTD | PMID:11414682 |
| thiourea | multiple interactions | ISO | RGD:734270 | 6480464 | Buthionine Sulfoximine inhibits the reaction [FMO3 protein results in increased susceptibility to Thiourea] | CTD | PMID:12093470 |
| thiourea | increases response to substance | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased susceptibility to Thiourea | CTD | PMID:12093470 |
| trimethylamine | affects metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 gene polymorphism affects the metabolism of trimethylamine | CTD | PMID:17050781 PMID:17142560 |
| trimethylamine | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of trimethylamine | CTD | PMID:12214664 more ... |
| trimethylamine | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of trimethylamine | CTD | PMID:17142560 more ... |
| trimethylamine | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of trimethylamine | CTD | PMID:17050781 more ... |
| trimethylamine | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of trimethylamine | CTD | PMID:17050781 more ... |
| trimethylamine | affects metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 gene polymorphism affects the metabolism of trimethylamine | CTD | PMID:17142560 PMID:17050781 |
| trimethylamine | multiple interactions | EXP | | 6480464 | trimethylamine inhibits the reaction [FMO3 protein results in increased oxidation of Methimazole] | CTD | PMID:11414682 |
| trimethylamine | increases oxidation | ISO | RGD:734270 | 6480464 | FMO3 results in increased oxidation of trimethylamine | CTD | PMID:16601883 |
| trimethylamine | increases oxidation | EXP | | 6480464 | FMO3 protein results in increased oxidation of trimethylamine | CTD | PMID:11414682 |
| trimethylamine | increases oxidation | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased oxidation of trimethylamine | CTD | PMID:11414682 |
| trimethylamine | increases metabolic processing | ISO | RGD:734270 | 6480464 | FMO3 protein results in increased metabolism of trimethylamine | CTD | PMID:17142560 more ... |
| valproic acid | decreases expression | ISO | RGD:734271 | 6480464 | Valproic Acid results in decreased expression of FMO3 mRNA | CTD | PMID:17292431 |